206 related articles for article (PubMed ID: 9702785)
21. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene.
Sasaki S; Warita H; Murakami T; Abe K; Iwata M
Acta Neuropathol; 2004 May; 107(5):461-74. PubMed ID: 15029445
[TBL] [Abstract][Full Text] [Related]
22. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.
De Vos KJ; Chapman AL; Tennant ME; Manser C; Tudor EL; Lau KF; Brownlees J; Ackerley S; Shaw PJ; McLoughlin DM; Shaw CE; Leigh PN; Miller CCJ; Grierson AJ
Hum Mol Genet; 2007 Nov; 16(22):2720-2728. PubMed ID: 17725983
[TBL] [Abstract][Full Text] [Related]
23. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
[TBL] [Abstract][Full Text] [Related]
24. Deficits in axonal transport precede ALS symptoms in vivo.
Bilsland LG; Sahai E; Kelly G; Golding M; Greensmith L; Schiavo G
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20523-8. PubMed ID: 21059924
[TBL] [Abstract][Full Text] [Related]
25. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.
Martin LJ
Rev Neurosci; 2007; 18(2):115-36. PubMed ID: 17593875
[TBL] [Abstract][Full Text] [Related]
26. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice.
Tobisawa S; Hozumi Y; Arawaka S; Koyama S; Wada M; Nagai M; Aoki M; Itoyama Y; Goto K; Kato T
Biochem Biophys Res Commun; 2003 Apr; 303(2):496-503. PubMed ID: 12659845
[TBL] [Abstract][Full Text] [Related]
27. High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation.
Wang J; Xu G; Borchelt DR
Neurobiol Dis; 2002 Mar; 9(2):139-48. PubMed ID: 11895367
[TBL] [Abstract][Full Text] [Related]
28. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
29. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity.
Bendotti C; Calvaresi N; Chiveri L; Prelle A; Moggio M; Braga M; Silani V; De Biasi S
J Neurol Sci; 2001 Oct; 191(1-2):25-33. PubMed ID: 11676989
[TBL] [Abstract][Full Text] [Related]
30. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking.
Laird FM; Farah MH; Ackerley S; Hoke A; Maragakis N; Rothstein JD; Griffin J; Price DL; Martin LJ; Wong PC
J Neurosci; 2008 Feb; 28(9):1997-2005. PubMed ID: 18305234
[TBL] [Abstract][Full Text] [Related]
31. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS.
Lobsiger CS; Garcia ML; Ward CM; Cleveland DW
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10351-6. PubMed ID: 16002469
[TBL] [Abstract][Full Text] [Related]
32. A mouse model of familial amyotrophic lateral sclerosis expressing a mutant superoxide dismutase 1 shows evidence of disordered transport in the vasopressin hypothalamo-neurohypophysial axis.
González de Aguilar JL; Gordon JW; René F; Lutz-Bucher B; Kienlen-Campard P; Loeffler JP
Eur J Neurosci; 1999 Dec; 11(12):4179-87. PubMed ID: 10594643
[TBL] [Abstract][Full Text] [Related]
33. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.
Williamson TL; Bruijn LI; Zhu Q; Anderson KL; Anderson SD; Julien JP; Cleveland DW
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9631-6. PubMed ID: 9689132
[TBL] [Abstract][Full Text] [Related]
34. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons.
Pardo CA; Xu Z; Borchelt DR; Price DL; Sisodia SS; Cleveland DW
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):954-8. PubMed ID: 7862672
[TBL] [Abstract][Full Text] [Related]
35. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations.
Jaarsma D; Rognoni F; van Duijn W; Verspaget HW; Haasdijk ED; Holstege JC
Acta Neuropathol; 2001 Oct; 102(4):293-305. PubMed ID: 11603803
[TBL] [Abstract][Full Text] [Related]
36. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation.
Ferrante RJ; Shinobu LA; Schulz JB; Matthews RT; Thomas CE; Kowall NW; Gurney ME; Beal MF
Ann Neurol; 1997 Sep; 42(3):326-34. PubMed ID: 9307254
[TBL] [Abstract][Full Text] [Related]
37. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site.
Wang J; Xu G; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2002 Jul; 10(2):128-38. PubMed ID: 12127151
[TBL] [Abstract][Full Text] [Related]
38. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
[TBL] [Abstract][Full Text] [Related]
39. Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology.
Wang L; Sharma K; Deng HX; Siddique T; Grisotti G; Liu E; Roos RP
Neurobiol Dis; 2008 Mar; 29(3):400-8. PubMed ID: 18054242
[TBL] [Abstract][Full Text] [Related]
40. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.
Wang J; Slunt H; Gonzales V; Fromholt D; Coonfield M; Copeland NG; Jenkins NA; Borchelt DR
Hum Mol Genet; 2003 Nov; 12(21):2753-64. PubMed ID: 12966034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]